Esther I. Verhoef

1.6k citations

36 papers · 1.0k indexed · h-index 18

Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 20
Cancer Research top 10%
- Cancer, Lipids, and Metabolism 5
Rheumatology top 5%
- Urologic and reproductive health conditions 2
Biophysics top 10%
Oncology
- Cancer Cells and Metastasis 3
Molecular Biology
- Molecular Biology Techniques and Applications 4
- Ubiquitin and proteasome pathways 2
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 3

Co-authors: Geert J.L.H. van Leenders Monique J. Roobol Charlotte F. Kweldam Theodorus van der Kwast Eva Hollemans Chris H. Bangma Daan Nieboer Intan P.E.D. Kümmerlin
Cited by: Pulmonary and Respiratory Medicine Cancer Research Rheumatology
Journals: Cancer Research (2 papers)Oncogene (1 paper)European Urology (1 paper)
Partner nations: Netherlands Canada Germany

In The Last Decade

Esther I. Verhoef

35 papers receiving 1.0k citations

Peers

Countries citing papers authored by Esther I. Verhoef

Since Specialization

Citations

This map shows the geographic impact of Esther I. Verhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther I. Verhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther I. Verhoef more than expected).

Fields of papers citing papers by Esther I. Verhoef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther I. Verhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther I. Verhoef. The network helps show where Esther I. Verhoef may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Esther I. Verhoef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esther I. Verhoef Line = papers co-authored together Esther I. Verhoef links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of intraductal‐to‐invasive spatial transitions in prostate cancer: proposal for a new unifying model on intraductal carcinogenesis Histopathology ·L. Lucia Rijstenberg,Hridya Harikumar,Esther I. Verhoef,Thierry van den Bosch,Roselyne Choinière,Martin E. van Royen,Geert J.L.H. van Leenders	2025	0
2	Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling Cells ·Annelies Van Hemelryk,Ingrid Tomljanović,Corrina M.A. de Ridder,Debra Stuurman,Wilma J. Teubel,Sigrun Erkens‐Schulze,Esther I. Verhoef,Sebastiaan Remmers,Amrish J. Mahes,Geert J.L.H. van Leenders,Martin E. van Royen,Harmen J.G. van de Werken,Magda Grudniewska,Guido Jenster,Wytske M. van Weerden	2022	8
3	Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients Modern Pathology ·Tim Hansum,Eva Hollemans,Esther I. Verhoef,Chris H. Bangma,John Rietbergen,Susanne Osanto,Rob C.M. Pelger,Tom van Wezel,Henk G. van der Poel,Elise M. Bekers,Jozien Helleman,Sebastiaan Remmers,Geert J.L.H. van Leenders	2021	13
4	Clinicopathological characteristics of glomeruloid architecture in prostate cancer Modern Pathology ·Eva Hollemans,Esther I. Verhoef,Chris H. Bangma,John Rietbergen,Susanne Osanto,Rob C.M. Pelger,Tom van Wezel,Henk G. van der Poel,Elise M. Bekers,Jozien Helleman,Monique J. Roobol,Geert J.L.H. van Leenders	2020	7
5	Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients Modern Pathology ·Eva Hollemans,Esther I. Verhoef,Chris H. Bangma,John Rietbergen,Susanne Osanto,Rob C.M. Pelger,Tom van Wezel,Henk G. van der Poel,Elise M. Bekers,Jozien Helleman,Monique J. Roobol,Geert J.L.H. van Leenders	2020	37
6	Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies Archives of Pathology & Laboratory Medicine ·Esther I. Verhoef,Charlotte F. Kweldam,Intan P.E.D. Kümmerlin,Daan Nieboer,Chris H. Bangma,Luca Incrocci,Theodorus van der Kwast,Monique J. Roobol,Geert J.L.H. van Leenders	2020	2
7	Combined transmission, dark field and fluorescence microscopy for intact, 3D tissue analysis of biopsies Journal of Biomedical Optics ·Marius I. Boamfa,Michel J. A. Asselman,Roland C. M. Vulders,Esther I. Verhoef,Martin E. van Royen,P. J. van der Zaag	2020	5
8	Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns Modern Pathology ·Esther I. Verhoef,Wiggert A. van Cappellen,Johan A. Slotman,Gert‐Jan Kremers,Patricia C. Ewing‐Graham,Adriaan B. Houtsmuller,Martin E. van Royen,Geert J.L.H. van Leenders	2019	29
9	Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer The Prostate ·Diederick Duijvesz,Giovanny Rodriguez Blanco,A. Marije Hoogland,Esther I. Verhoef,Lennard J. M. Dekker,Monique J. Roobol,Geert J.L.H. van Leenders,Theo M. Luider,Guido Jenster	2019	12
10	Epithelial–Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression Cancer Research ·Kimberley Kolijn,Esther I. Verhoef,Marcel Smid,René Böttcher,Guido Jenster,Reno Debets,Geert J.L.H. van Leenders	2018	43
11	Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis Modern Pathology ·Eva Hollemans,Esther I. Verhoef,Chris H. Bangma,John Rietbergen,Jozien Helleman,Monique J. Roobol,Geert J.L.H. van Leenders	2018	78
12	Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model EBioMedicine ·Lisanne Mout,Ronald de Wit,Debra Stuurman,Esther I. Verhoef,Ron H.J. Mathijssen,Corrina de Ridder,Martijn P. Lolkema,Wytske M. van Weerden	2017	13
13	CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer Oncogene ·Eugenio Zoni,L. Chen,Sofia Karkampouna,Zoraide Granchi,Esther I. Verhoef,Federico La Manna,Jonathan A. Kelber,Rob C.M. Pelger,Michael D. Henry,B. Ewa Snaar‐Jagalska,Geert J.L.H. van Leenders,Lijkele Beimers,Peter Kloen,Peter C. Gray,Gabri van der Pluijm,Marianna Kruithof‐de Julio	2017	35
14	Three‐dimensional microscopic analysis of clinical prostate specimens Histopathology ·Martin E. van Royen,Esther I. Verhoef,Charlotte F. Kweldam,Wiggert A. van Cappellen,Gert‐Jan Kremers,Adriaan B. Houtsmuller,Geert J.L.H. van Leenders	2016	57
15	Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma European Journal of Cancer ·Charlotte F. Kweldam,Intan P.E.D. Kümmerlin,Daan Nieboer,Esther I. Verhoef,Ewout W. Steyerberg,Luca Incrocci,Chris H. Bangma,Theodorus van der Kwast,Monique J. Roobol,Geert J. van Leenders	2016	56
16	Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy Modern Pathology ·Charlotte F. Kweldam,Intan P.E.D. Kümmerlin,Daan Nieboer,Esther I. Verhoef,Ewout W. Steyerberg,Theodorus van der Kwast,Monique J. Roobol,Geert J. van Leenders	2016	163
17	Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer Oncotarget ·A. Marije Hoogland,René Böttcher,Esther I. Verhoef,Guido Jenster,Geert J.L.H. van Leenders	2016	13
18	Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer Oncotarget ·Kimberley Kolijn,Esther I. Verhoef,Geert J.L.H. van Leenders	2015	45
19	SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer Cancer Research ·Veerander P.S. Ghotra,Shuning He,Geertje van der Horst,Steffen Nijhoff,Hans de Bont,Annemarie Lekkerkerker,Richard A. J. Janssen,Guido Jenster,Geert J.L.H. van Leenders,A. Marije Hoogland,Esther I. Verhoef,Zuzanna Baranski,Jiangling Xiong,Bob van de Water,Gabri van der Pluijm,B. Ewa Snaar‐Jagalska,Erik H.J. Danen	2014	57
20	Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease The Prostate ·A. Marije Hoogland,Esther I. Verhoef,Monique J. Roobol,Fritz H. Schröder,Mark F. Wildhagen,Theodorus van der Kwast,Guido Jenster,Geert J.L.H. van Leenders	2013	38

About Esther I. Verhoef

Esther I. Verhoef is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Biophysics, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Prostate Cancer Diagnosis and Treatment (20 papers), Cancer, Lipids, and Metabolism (5 papers), Molecular Biology Techniques and Applications (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Cancer Cells and Metastasis (3 papers), Ubiquitin and proteasome pathways (2 papers) and Urologic and reproductive health conditions (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (681 citations), Cancer Research (219 citations) and Rheumatology (190 citations). Esther I. Verhoef has collaborated with scholars based in Netherlands, Canada and Germany. Frequent co-authors include Geert J.L.H. van Leenders, Monique J. Roobol, Charlotte F. Kweldam, Theodorus van der Kwast, Eva Hollemans, Chris H. Bangma, Daan Nieboer, Intan P.E.D. Kümmerlin, Geert J. van Leenders and Jozien Helleman. Their work appears in journals such as Cancer Research, Oncogene and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact